BENGALURU : India's Hetero Labs Ltd has priced its generic version of remdesivir, Gilead's experimental COVID-19 drug, at ₹5,400 ($71) per 100-milligram vial, the drugmaker said on Wednesday, as it prepares to ship them to hospitals in the country.The privately held company said it would supply 20,000 vials of the drug.
Fellow Indian drug firm Cipla Ltd had said on Tuesday that its own version of the antiviral drug remdesivir would be priced below ₹5,000.Cipla and Hetero are among a bevy of drugmakers which have licensing agreements with US-based Gilead Sciences Inc , the original manufacturer of remdesivir, to make and sell the drug in 127 low-and middle-income countries.India has approved the generic versions made by Cipla and Hetero for.